Unpublished conference/Abstract (Scientific congresses and symposiums)
MONALEESA-3 : A phase III study of Ribociclib (LEE011) with Fulvestrant for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in postmenopausal women who have received no or only one line of prior endocrine therapy
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Service d'oncologie médicale
Pivot, X.
Martin, M.
De Laurentiis, M.
Blackwell, K.
Esteva, F.J.
Germa, C.
Tang, Z.
Dhuria, S.
Slamon, D.J.
Language :
English
Title :
MONALEESA-3 : A phase III study of Ribociclib (LEE011) with Fulvestrant for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in postmenopausal women who have received no or only one line of prior endocrine therapy
